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randomised controlled trial of a good practice
approach to treatment of adolescent obesity
in Kuwait
Shurooq A Boodai1*, John H McColl2 and John J Reilly3Abstract
Background: Few randomised controlled trials (RCTs) of interventions for the treatment of adolescent obesity have
taken place outside the western world. This RCT tested whether a simple ‘good practice’ intervention for the
treatment of adolescent obesity would have a greater impact on weight status and other outcomes than a referral
to primary care (control) in adolescents in Kuwait City.
Methods: We report on an assessor-blinded RCT of a treatment intervention in 82 obese 10- to 14-year-olds (mean
age 12.4, SD 1.2 years), randomised to a good practice treatment or primary care control group over 6 months. The
good practice intervention was intended as relatively low intensity (6 hours contact over 24 weeks, group-based),
aiming to change sedentary behaviour, physical activity, and diet. The primary outcome was a change in body mass
index (BMI) Z score; other outcomes were changes in waist circumference and blood pressure.
Results: The retention of subjects to follow up was acceptable (n = 31 from the intervention group, and n = 32 from
the control group), but engagement with both the intervention and control treatment was poor. Treatment had no
significant effect on BMI Z score relative to control, and no other significant benefits to intervention were observed.
Conclusions: The trial was feasible, but highlights the need to engage obese adolescents and their families in the
interventions being trialled. The trial should inform the development of future adolescent obesity treatment trials in the
Gulf States with the incorporation of qualitative assessment in future intervention trials.
Trial registration: RCT Registered as National Adolescent Treatment Trial for Obesity in Kuwait (NATTO):
www.controlled-trials.com/ISRCTN37457227, 1 December 2009.
Keywords: obesity, overweight, adolescents, treatment, BMI, randomised controlled trialBackground
Prevalence of child and adolescent obesity has increased
dramatically in recent years in Kuwait, [1,2], as in much of
the rest of the world. While prevention of obesity is para-
mount, most preventive interventions have had only a
modest impact, and there is a need to offer weight man-
agement interventions for adolescents who are already* Correspondence: s.boodai.1@research.gla.ac.uk
1University of Glasgow School of Medicine, Level 3 New Lister Building, GRI,
10 Alexander Parade, Glasgow, Scotland
Full list of author information is available at the end of the article
© 2014 Boodai et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.obese [3,4], particularly given the large number of serious
short-term and long-term co-morbidities of adolescent
obesity [5,6].
Despite the importance of treatment interventions for
adolescent obesity, recent systematic reviews have found
almost no evidence on treatment interventions outside the
western world [3]. Specifically, the recent Cochrane review
[3] found 29 eligible trials of adolescent obesity treatment,
and none of these were from the Arab world (16 from
North America, 7 from Europe and Australia; 3 from Asia;
and 2 from Israel). The primary aim of the present studyLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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intervention for the treatment of adolescent obesity in
Kuwait would have a greater effect on primary and second-
ary outcomes than allocation to a control group. The sec-
ondary aims were to test the feasibility of conducting such
a trial in Kuwait and to test the feasibility of using a good
practice intervention and referral to primary care as a con-
trol condition, with a view to developing improved obesity
treatment RCTs in Kuwait and the other Gulf States.
Methods
Participants
The study was conducted at Al Faiha polyclinic (primary
care clinic) during 2009. For entry into the study, adoles-
cents, ages 10 to 14 years had to be obese (body mass
index (BMI) above the 95th percentile [7]), have at least
one parent who expressed a willingness to attend the
intervention described below if allocated to it, and have no
serious underlying medical condition that might be either
a cause or consequence of their obesity. Adolescents were
recruited from their schools after BMI and health screen-
ing was conducted by one of the researchers (SAB). The
schools and residences of all participants were located in
the capital, and both the venue for the intervention
(Al Faiha polyclinic) and the venue for the control primary
care clinic were also in the capital to ensure that distance
was not an issue hindering attendance. Ethical approval
was obtained from the Ethics Committee for Medical Re-
search, Ministry of Health of Kuwait (ref MPH/112), and
written informed consent was obtained from both parents
and adolescents.
Randomisation and allocation concealment
Participating adolescents attended a research clinic
where all baseline measures (see below) were taken,
then assigned a unique study code prior to random allo-
cation into the treatment or control group. To ensure
concealment of allocation, codes were sent electronic-
ally to a statistician (JHM) who produced a computer
generated randomisation list that allocated participants
to intervention or control group, with participants bal-
anced for gender in blocks of 10. The statistician in-
formed the researcher responsible for delivering the
intervention (SAB) of the allocation, and families were
invited to intervention or control groups as appropriate.
Intervention
In brief, the intervention was intended as a relatively low
intensity (6 sessions, 1 hour contact time per session, deliv-
ered as a group session) programme, which might be read-
ily generalisable if evidence of feasibility and efficacy was
obtained from the present study. The intervention was de-
livered to the adolescents and their parents in group-
discussion fashion over a 24-week period by a physicianwith specialist training in Nutrition (SAB) and the study
dietician. The programme was adapted from the Scottish
Childhood Obesity Treatment Trial (SCOTT), which tested
a ‘good practice’ treatment intervention in Scotland [8,9].
Parents were provided with treatment materials that were
adapted from those used in SCOTT [9]. The intervention is
described here as a ‘good practice’ intervention on two
grounds. First, because it focused on changing the behav-
iours recommended as the key targets in recent evidence-
based management guidelines [10-12] for the treatment of
adolescent obesity (reduction in sedentary behaviour, par-
ticularly screen-media use; diet, using a modified version of
the ‘traffic light diet’ system [8]; and promotion of physical
activity). Second, the intervention incorporated theoretically
based behaviour change techniques to all three of the tar-
geted behaviours [8]: exploration of the pros and cons of
changes in diet, physical activity, and sedentary behaviour;
exploration of motivation to change diet, physical activity,
and sedentary behaviour; self-monitoring of sedentary be-
haviour (recording of screen time in diaries), diet, and phys-
ical activity (recording of walking, sport, and physically
active play in a diary); identifying the main barriers to be-
haviour change and problem solving in relation to these
barriers; goal setting in relation to diet, physical activity,
and sedentary behaviour; and relapse prevention.
The intervention group was further divided into boys
(n = 21, each attending with at least one parent) and girls
(n = 20, each attending with at least one parent) groups
in accordance with cultural norms of the Kuwaiti popula-
tion, and their sessions were delivered on two consecutive
days. Any adolescent who attended the intervention ses-
sion alone was welcomed, although ideally at least one
parent should have been present.
Control group
Primary care-based treatment of child and adolescent
obesity in Kuwait is somewhat limited, as in many other
countries, but it was felt ethically and scientifically appro-
priate to use referral to primary care as a control condition
in the present study. Adolescents, and their parents, who
were allocated randomly to the control group were there-
fore informed that they were obese and advised to attend
primary care.
Outcome measures and blinding
BMI Z scores were calculated based on US CDC 2000 ref-
erence data [7] using the software available at http://stokes.
chop.edu/web/zscore/index.php. Outcome measures were
made at baseline and again at 6 months (26 weeks) after
the start of the intervention by the same trained research
assistants who were blinded to group allocation and were
not involved in delivery of the treatment intervention.
Blood pressure was measured when the participant was
sitting quietly in the upright position, with the correct
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peated three times and the average of the three readings
was taken.
The primary study outcome measure was change in
BMI Z score. Weight was measured to 0.1 kg in light in-
door clothing with children not wearing shoes, and height
was measured to 0.1 cm with a portable stadiometer
(Leicester Height Measure, SECA, London, UK) and ado-
lescents not wearing shoes. Secondary outcomes were
waist circumference and blood pressure.
Sample size, power, and statistical analysis
No local data were available upon which to base a power
calculation. The present study was therefore powered
using BMI data from the Scottish SCOTT RCT [8], which
was used to develop the treatment intervention. With a
between-group difference in the change in BMI Z-score
of -0.25 at 6 months (which is a small change in BMI Z
score, as discussed below) and a SD of change in BMI Z
score of 0.21, giving a delta of 1.15, a sample size of
around 30 adolescents per arm at 6 months would give
90% power at the 0.05 significance level. Dropout from the
trial could not be predicted, but it was hoped that entering
around 90 adolescents would make sufficient allowance
for attrition during the 6-month study to leave around 30
participants per arm at the end of the trial.
Outcomes were analysed in two ways. First, changes in
outcome variables within each group (intervention and
control) between baseline and 6-month follow-up are pre-
sented. The issue of whether changes in outcome variables
differed significantly between groups (intervention versus
control) was examined using independent sample t-tests.
The analysis was intention-to-treat, where we used data
from all adolescents for whom data were available on the
basis of the group to which they were allocated, regardless
of their adherence to the protocol (attendance).
Feasibility of the trial: treatment intervention and control
conditions
Since the present study was the first of its kind in Kuwait, it
was not considered as a ‘definitive trial’ [13] but rather as
the initiation of a process which should lead to a more de-
finitive trial subsequently [13]. Feasibility of the trial and
feasibility of the trial interventions were measured by sum-
marising the extent of sample attrition (dropout) over the
6-month period, the extent of missing data, and recording
attendance at intervention and control treatments.
Results
Flow of participants through the trial, flow through the
interventions, and participant characteristics
Figure 1 describes the flow of participants through the trial
and through the intervention. Of the 82 participants en-
tered at baseline, 63 (77%) attended for outcome measuresat the 6-month follow-up. There were no significant differ-
ences at baseline between intervention and control groups
for adolescent age, anthropometric measures and weight
status (Table 1).
Changes in primary and secondary outcomes within and
between groups
Table 2 provides data on change in BMI Z scores, blood
pressures and waist circumference. There were no statisti-
cally significant differences within the two groups over the
6 months for any of the anthropometric measures. There
were also no significant differences between the groups for
the 6-month changes in anthropometry (Table 2). Only 7
of the 31 adolescents in the intervention group at the end
of the study maintained or lost weight over the 6 months,
while 5/32 in the control group maintained or lost weight
over the 6 months.
Discussion
Main findings, study implications, and comparisons with
other evidence
While it seems that no previous adolescent obesity treat-
ment RCTs have been published from Kuwait or the other
Gulf States, the present study suggests that conducting
randomised controlled trials of adolescent obesity treat-
ment interventions in Kuwait is feasible. Retention in the
trial was acceptable and not strikingly dissimilar to that re-
ported in other adolescent obesity treatment trials that took
place over a similar timescale [3]. Luttikhuis and colleagues
in the recent Cochrane review described attrition in the eli-
gible adolescent obesity treatment trials (of at least 6
months duration) as ranging from 0 to 43% by the end of
the intervention [3]. An expansion of the evidence base on
interventions to treat adolescent obesity is required because
most obese adolescents now live outside western countries
[14]. However, the recent Cochrane review [3] found no eli-
gible RCT from the Arab world.
The present study also suggests that adherence to obes-
ity interventions in obese adolescents and their families in
Kuwait might be very poor. While retention in the trial
was acceptable, engagement with the interventions offered
was limited: only 12 participants (29% of the sample)
attended ≥4 sessions, and the control group families did
not attend any sessions at primary care. The reasons for
poor adherence to both the study intervention and control
treatments are probably complex and a detailed discussion
of them is beyond the scope of the present study. How-
ever, a number of the adolescents and their families
expressed a low degree of concern about obesity on being
given the diagnosis and at the treatment sessions which
they attended, and the poor attendance is consistent with
this view. The fact that attendance was negligible even in
the control group implies a low degree of concern about
obesity rather than any specific non-engagement with the
Figure 1 CONSORT 2010 flow diagram.
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cents in Kuwait city [15] we reported that health-related
quality of life was not impaired in obese adolescents rela-
tive to their healthy weight peers; this is an unusual find-
ing [16,17], and it seemed to reflect a cultural difference
between western and Kuwaiti societies, with a reduced
concern over obesity in Kuwait [15]. Of note, we analysed
blood samples from 80 out of the 82 participants in
NATTO for cardiometabolic risk factors at baseline;
however, results of the analyses were only available afterTable 1 Characteristics of participating adolescents at baselin
Characteristic Full sample
n = 82
Mean (SD)
Age (years) 12.4 (1.2)
Male/female 42/40
Body mass index Z score 2.2 (0.3)
Systolic blood pressure (mmHg) 122.2 (10.4)
Diastolic blood pressure 77.5 (7.6)
Waist circumference (cm) 93.5 (12.1)
Attendance at the intervention group and control group sessions was low and is shthe end of the trial. Had these results been available,
they may have had an impact on the motivation to at-
tend of both the intervention and the control groups.
Several studies have shown multiple cardiometabolic
risk factors in obese adolescents both in Kuwait [18]
and internationally [19,20].
Exploring the reasons for non-attendance and non-
adherence to treatment and investigating the treatment
preferences of obese adolescents and their families would be
important for future adolescent obesity treatment researche
Treatment group Control group
n = 41 n = 41
Mean (SD) Mean (SD)
12.4 (1.2) 12.4 (1.2)
21/20 21/20
2.2 (0.3) 2.2 (0.3)
122.0 (12.3) 122.0 (8.2)
76.0 (8.5) 79.1 (6.4)
93.0 (12.7) 94.0 (11.6)
own in Figure 1.
Table 2 Six-month changes in outcome measures within and between-groups (n = 31 treatment group versus
32 controls)
Outcome Intervention group within-group
change mean (SD)
Control group within-group
change mean (SD)
Between-group difference,
mean (95% CI), P value
Body mass index Z score 0.0 (0.1) 0.0 (0.2) 0.0 (-0.1; 0.1), 0.6
Systolic blood pressure (mmHg) 0.4 (6.7) 0.6 (4.8) 0.3 (-2.7; 3.2), 0.9
Diastolic blood pressure (mmHg) 2.9 (6.2) 1.1 (5.8) -1.8 (-4.8, 1.3), 0.2
Waist circumference (cm) 4.9 (5.8) 3.5 (5.7) -1.4 (-4.3; 1.5), 0.3
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Research Council Framework on the Development and
Evaluation of Complex Interventions [13] recommends an
approach in which interventions are developed in conjunc-
tion with study participants, and qualitative studies are used
to understand treatment preferences.
The degree of change in body weight status that might
be desirable in an adolescent obesity treatment interven-
tion is uncertain [10-12], but improvements in cardiomet-
abolic risk factors probably require much greater changes
than were observed in the present study, [21,22]. Weight
maintenance or modest weight loss is usually recom-
mended for adolescent obesity treatment interventions
[10-12], but in the present study, only a minority of partic-
ipants maintained or lost weight. Since adherence to treat-
ment ranged from limited to absent in the present study,
the actual ‘dose’ of obesity treatment was probably also
very low, amounting to little more than the confirmation
to the adolescents and their families that they were obese
with some evidence-based advice. The present study is
therefore consistent with some others (for example, [23])
in suggesting that diagnosis of obesity plus good advice
alone is likely to have null or minimal effects on energy
balance of obese adolescents.
Study strengths and weaknesses
The principal strengths of the present study were the high
level evidence obtained, with adherence to the CONSORT
statement on conduct and reporting of RCTs [24]; the fact
that the trial was powered adequately, in contrast to a
number of previous trials in this area [3]; development
and testing of a potentially generalisable intervention; and
completing a challenging adolescent obesity treatment
RCT [25] in the novel setting of a Gulf State.
The present study also had a number of weaknesses.
Longer term obesity treatment trials are desirable, and a 6-
month follow-up is considered the minimum desirable in
the most recent Cochrane review of paediatric obesity
treatment RCTs [3]. An assessment of parent and adoles-
cent perspectives on the treatment programme would have
been desirable in order to both understand the current
intervention better and to inform future treatment inter-
ventions [13,26,27]. Future intervention trials in Kuwaitmight also find it useful to focus treatment at other popu-
lation subgroups (for example, younger or older partici-
pants, or to tailor treatment to boys or to girls), but this
was not possible in the present study due to resource
limitations.
Conclusions
The present study suggests that trials of obesity treat-
ment interventions in adolescents in Kuwait are feasible,
but that the success of future trials will depend on ad-
dressing the problem of low adherence to treatment.
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